UpDoc's FDA-cleared V1.0 platform uses a large language model to talk with type 2 diabetes patients and adjust insulin doses within physician-approved bounds, and it is now deployed at Cleveland Clinic, AHN, and UCSF, raising questions about how far generative AI should go in direct patient care.
Atlanta startup CheckWellCall has soft-launched an AI-powered daily wellness check-in call for seniors, automating structured voice conversations that flag deviations from a resident's baseline for family caregivers or senior living staff to follow up on.
As the FDA continues weighing national rules following a November 2025 advisory committee meeting, Illinois, Nevada and Utah have already enacted differing state laws on AI therapy chatbots in 2026, from outright bans to disclosure requirements, creating a fragmented compliance landscape.
HCA Healthcare and Google Cloud are piloting Nurse Handoff, a generative AI tool that standardizes shift-change patient handoffs at five hospitals, with nurses rating it accurate in over 85% of cases; the company plans to scale it to its 100,000-nurse workforce if results hold.
Temple University Hospital has fully deployed an AI insulin-dosing tool called EndoTool across its hospitals, producing a more than twofold reduction in dangerous low-blood-sugar episodes among diabetic patients while keeping nurses in the approval loop.
A Nature Communications study published August 12, 2026 by Dana-Farber and Mass General Brigham researchers found that genomic screening of newborn blood spots could flag childhood cancer risk years before diagnosis, with AI-driven variant analysis making population-scale screening feasible.
Sheba Medical Center has become the first hospital outside the U.S. to gain access to OpenAI's dedicated healthcare AI models, a deal signed in July 2026 that will bring ChatGPT Health to Israeli physicians for clinical decision support and documentation.
A Cleveland Clinic-led foundation model trained on 9,608 overnight sleep studies found more than double the mortality risk in its highest-risk patient group, a signal the standard apnea-hypopnea index completely missed, according to new Nature Communications research.
Novo Nordisk named AWS its preferred cloud partner and opened a London co-innovation hub to speed drug discovery with agentic AI, with more than 25,000 employees already using Bedrock-based tools for research and operations.
A new Nature Medicine framework called SIM-VAIL tested nine leading AI chatbots against simulated users with depression, psychosis, and other conditions, uncovering 'Vulnerability-Amplifying Interaction Loops' where seemingly supportive replies reinforce harmful thinking over a conversation.